Clinical Trials
All Clinical Trials - Page 70 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT00166725Phase 2Completed
Effects of Octreotide Acetate on Circulating Levels of Chromogranin A in Advanced Prostate Cancer Patients
Octreotide
- NCT00149188Phase 4Completed
Somatuline Autogel: Acromegaly Self/Partner Injection Study
Lanreotide
- NCT01060488Phase 3Completed
Comparative Validation of the Growth Hormone Releasing Hormone and Arginine Test for the Diagnosis of Adult Growth Hormone Deficiency
Sermorelin
- NCT00635258N/ACompleted
Administration of GnRH Antagonist to Oocyte Donation Recipients
Gonadorelin
- NCT01014507Phase 2Completed
Protection of Ovarian Function in Female Patients With Hodgkin Lymphoma
Gonadorelin
- NCT00088595Phase 2Completed
Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors
Octreotide
- NCT00993356Phase 2Unknown
Preoperative Lanreotide Treatment in Acromegalic Patients With Macroadenomas
Lanreotide
- NCT01615978Phase 1Completed
Safety and Tolerability of Liraglutide in Japanese Subjects With Type 2 Diabetes
Liraglutide
- NCT01876849Phase 3Completed
An Open-Label Study Examining the Long-Term Safety of Exenatide Given Twice Daily to Patients With Type 2 Diabetes Mellitus
Exenatide
- NCT01611571Phase 3Completed
Combination Risedronate - Parathyroid Hormone Trial in Male Osteoporosis
Teriparatide
- NCT00065637Phase 3Completed
Once Weekly Parathyroid Hormone for Osteoporosis
Teriparatide
- NCT00108355Phase 4Completed
Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis
Octreotide
- NCT00466856Phase 2Terminated
Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors
Octreotide
- NCT00075868Phase 3Completed
Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
Octreotide
- NCT00170742Phase 3Terminated
Study to Assess the Efficacy and Safety of Monthly Octreotide Intramuscular Injections in Patients With Proliferative Diabetic Retinopathy After Lasercoagulation This Study is Not Being Conducted in the United States.
Octreotide
- NCT00072839Phase 2Completed
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease
Teduglutide
- NCT00066703Phase 3Completed
Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
Gonadorelin
- NCT00417144Phase 4Unknown
Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients
Gonadorelin
- NCT00082407Phase 3Completed
Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin
Exenatide
- NCT00532207Phase 3Completed
Study of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis
Teriparatide
- NCT00193856Phase 3Completed
RADAR Trial - Randomised Androgen Deprivation and Radiotherapy
Gonadorelin
- NCT00068601Phase 3Completed
S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Gonadorelin
- NCT00206297Phase 3Completed
The Effect of Prolonged Pramlintide Infusion in Pediatric Diabetes
Pramlintide
- NCT00068029Phase 4Completed
Pegvisomant And Sandostatin LAR Combination Study
Octreotide
- NCT00816127N/ACompleted
Prevention of Bleeding in Patient With Cirrhosis Undergoing Dental Extraction
Desmopressin
- NCT00104741Phase 3Completed
Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer
Gonadorelin
- NCT00311636Phase 3Completed
Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery
Gonadorelin
- NCT00417066Phase 4Completed
Flexible GnRH Antagonist vs Flare up GnRH Agonist Protocol in Poor Responders
Gonadorelin
- NCT01620476Phase 1Completed
Safety and Tolerability of Liraglutide in Healthy Japanese Volunteers
Liraglutide
- NCT00085969Phase 2Completed
Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes Mellitus
Exenatide
- NCT00191893Phase 3Completed
Bone Effects of Teriparatide Following Alendronate
Teriparatide
- NCT00191802Phase 3Completed
Compliance and Acceptance of Teriparatide Injection in Severely Osteoporotic Patients
Teriparatide
- NCT00216372Phase 3Completed
Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosis
Lanreotide
- NCT00066807Phase 3Terminated
Premenopausal Endocrine Responsive Chemotherapy Trial
Gonadorelin
- NCT01078805N/ACompleted
Study of FORTEO Use in Subjects in the Community Setting
Teriparatide
- NCT00542984Phase 3Completed
Comparison Medications in the Treatment of Postmenopausal Women With Osteoporosis
Teriparatide
- NCT00064714Phase 2Completed
Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I Diabetes
Exenatide
- NCT00835211Phase 1Completed
Desmopressin Acetate 0.2 mg Tablets, Fasting
Desmopressin
- NCT00592566Phase 2/Phase 3Terminated
Desmopressin and Dexamethasone Adjunctive Treatment for Leptospirosis
Desmopressin
- NCT00124514Phase 2Completed
Triptorelin for Ovary Protection in Childhood Onset Lupus
Gonadorelin
- NCT00500110Phase 2Completed
Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer
Gonadorelin
- NCT00082381Phase 3Completed
Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin
Exenatide
- NCT00543023Phase 3Completed
A Study of the Treatment of Postmenopausal Women With Osteoporosis
Teriparatide
- NCT00234520N/ACompleted
A Study to Evaluate the Risk of Developing a Heart Condition Called Valvular Regurgitation in Patients With Acromegaly Treated With Either Lanreotide or Octreotide
Octreotide
- NCT00582556Phase 2Completed
Zometa on Bone Mineral Density in Prostate Cancer Patients Undergoing Androgen Ablation Therapy
Gonadorelin
- NCT00220194Phase 4Completed
A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate Cancer
Gonadorelin
- NCT00108004Phase 3Completed
Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus
Pramlintide
- NCT00532545Phase 4Completed
Bone Marker Changes With Teriparatide/Postmenopausal Osteoporosis
Teriparatide
- NCT00068042Phase 4Completed
A Study To Compare The Efficacy And Safety Of Pegvisomant To That Of Sandostatin Lar Depot In Patients With Acromegaly
Octreotide
- NCT00056654N/ACompleted
Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer
Gonadorelin